{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T03:10:01Z","timestamp":1793761801161,"version":"4.6.1"},"reference-count":69,"publisher":"American Chemical Society (ACS)","issue":"20","license":[{"start":{"date-parts":[[2022,10,6]],"date-time":"2022-10-06T00:00:00Z","timestamp":1665014400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Med. Chem."],"published-print":{"date-parts":[[2022,10,27]]},"DOI":"10.1021\/acs.jmedchem.2c00668","type":"journal-article","created":{"date-parts":[[2022,10,6]],"date-time":"2022-10-06T23:48:50Z","timestamp":1665100130000},"page":"13614-13628","source":"Crossref","is-referenced-by-count":56,"title":["Discovery, Chemistry, and Preclinical Development of Pritelivir, a Novel Treatment Option for Acyclovir-Resistant Herpes Simplex Virus Infections"],"prefix":"10.1021","volume":"65","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5670-4814","authenticated-orcid":true,"given":"Alexander","family":"Birkmann","sequence":"first","affiliation":[{"name":"AiCuris Anti-Infective Cures AG, 42117 Wuppertal, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne","family":"Bonsmann","sequence":"additional","affiliation":[{"name":"AiCuris Anti-Infective Cures AG, 42117 Wuppertal, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk","family":"Kropeit","sequence":"additional","affiliation":[{"name":"AiCuris Anti-Infective Cures AG, 42117 Wuppertal, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamara","family":"Pfaff","sequence":"additional","affiliation":[{"name":"AiCuris Anti-Infective Cures AG, 42117 Wuppertal, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manickam","family":"Rangaraju","sequence":"additional","affiliation":[{"name":"AiCuris Anti-Infective Cures AG, 42117 Wuppertal, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie","family":"Sumner","sequence":"additional","affiliation":[{"name":"AiCuris Anti-Infective Cures AG, 42117 Wuppertal, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Burkhard","family":"Timmler","sequence":"additional","affiliation":[{"name":"AiCuris Anti-Infective Cures AG, 42117 Wuppertal, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holger","family":"Zimmermann","sequence":"additional","affiliation":[{"name":"AiCuris Anti-Infective Cures AG, 42117 Wuppertal, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helmut","family":"Buschmann","sequence":"additional","affiliation":[{"name":"AiCuris Anti-Infective Cures AG, 42117 Wuppertal, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helga","family":"Ruebsamen-Schaeff","sequence":"additional","affiliation":[{"name":"AiCuris Anti-Infective Cures AG, 42117 Wuppertal, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"316","published-online":{"date-parts":[[2022,10,6]]},"reference":[{"key":"ref1\/cit1","doi-asserted-by":"publisher","DOI":"10.1093\/molbev\/msu185"},{"key":"ref2\/cit2","doi-asserted-by":"publisher","DOI":"10.1093\/ve\/vex026"},{"key":"ref3\/cit3","doi-asserted-by":"publisher","DOI":"10.12688\/f1000research.16157.1"},{"key":"ref4\/cit4","doi-asserted-by":"publisher","DOI":"10.3390\/v13071228"},{"key":"ref5\/cit5","doi-asserted-by":"publisher","DOI":"10.1016\/j.coviro.2016.01.013"},{"key":"ref6\/cit6","volume-title":"New Drug Development for Known and Emerging Viruses","author":"Birkmann A.","year":"2021"},{"key":"ref7\/cit7","unstructured":"FDA. n-Docosanol.\nPharmacology Review (1999). https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/2000\/020941s000_PharmR.pdf (accessed Sep 11, 2021)."},{"key":"ref8\/cit8","doi-asserted-by":"publisher","DOI":"10.1021\/jm00010a027"},{"key":"ref9\/cit9","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.72.9.6979-6987.1998"},{"key":"ref10\/cit10","doi-asserted-by":"publisher","DOI":"10.1038\/nm0402-386"},{"key":"ref11\/cit11","doi-asserted-by":"publisher","DOI":"10.1038\/nm0402-392"},{"key":"ref12\/cit12","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkq198"},{"key":"ref13\/cit13","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abf8668"},{"key":"ref14\/cit14","doi-asserted-by":"publisher","DOI":"10.1002\/cpdd.1138"},{"key":"ref15\/cit15","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00977-15"},{"key":"ref16\/cit16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jgar.2019.05.004"},{"key":"ref17\/cit17","doi-asserted-by":"publisher","DOI":"10.2174\/1568012043354242"},{"key":"ref18\/cit18","unstructured":"Fischer, R.; Bender, W.; Henninger, K.; Eckenberg, P.; Handke, G.; Keldenich, J.; Weber, O.; Kleymann, G.; Betz, U.; Hendrix, M.; Schneider, U.; Jensen, A.; Baumeister, J. WO 0147904, 2001 (Bayer AG)."},{"key":"ref19\/cit19","unstructured":"Betz, U.; Laich, T.; Bender, W.; Fischer, R.; Hendrix, M.; Kleymann, G. WO03000259, 2003 (Bayer AG)."},{"key":"ref20\/cit20","unstructured":"Schohe-Loop, R.; Betz, U.; Fischer, R.; Hendrix, M.; Kleymann, G.; Baumeister, J.; Bender, W.; Eckenberg, P.; Handke-Erg\u00fcden, G.; Henninger, K.; Jensen, A.; Keldenich, J.; Schneider, U.; Weber, O. WO03000260, 2003 (Bayer AG)."},{"key":"ref21\/cit21","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2018.02406"},{"key":"ref22\/cit22","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics7030072"},{"key":"ref23\/cit23","doi-asserted-by":"publisher","DOI":"10.1098\/rsob.210011"},{"key":"ref24\/cit24","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkn057"},{"key":"ref25\/cit25","doi-asserted-by":"publisher","DOI":"10.1099\/vir.0.011221-0"},{"key":"ref26\/cit26","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.46.6.1766-1772.2002"},{"key":"ref27\/cit27","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2006.11.006"},{"key":"ref28\/cit28","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1301150"},{"key":"ref29\/cit29","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.18189"},{"key":"ref30\/cit30","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2017.11.002"},{"key":"ref31\/cit31","doi-asserted-by":"publisher","DOI":"10.1177\/095632020701800104"},{"key":"ref32\/cit32","doi-asserted-by":"publisher","DOI":"10.1089\/jop.2007.0084"},{"key":"ref33\/cit33","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2013.08.024"},{"key":"ref34\/cit34","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02641-14"},{"key":"ref35\/cit35","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2010.11.002"},{"key":"ref36\/cit36","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2018.02483"},{"key":"ref37\/cit37","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiw129"},{"key":"ref38\/cit38","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.16.1.114-128.2003"},{"key":"ref39\/cit39","doi-asserted-by":"publisher","DOI":"10.1177\/095632020701800102"},{"key":"ref40\/cit40","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkm182"},{"key":"ref41\/cit41","doi-asserted-by":"publisher","DOI":"10.1007\/s00705-007-0964-7"},{"key":"ref42\/cit42","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2010.04.008"},{"key":"ref43\/cit43","unstructured":"AiCuris\nAnti-Infective Cures AG, unpublished results."},{"key":"ref44\/cit44","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.7b00183"},{"key":"ref45\/cit45","doi-asserted-by":"publisher","DOI":"10.1039\/C9MD00233B"},{"key":"ref46\/cit46","unstructured":"ICH guideline\nQ8 (R2) on pharmaceutical\ndevelopment (2014)."},{"key":"ref47\/cit47","unstructured":"ICH Q9 on quality risk management,\nstep 5 (2014)."},{"key":"ref48\/cit48","unstructured":"ICH Q10 on pharmaceutical quality\nsystem, step 5 (2014)."},{"key":"ref49\/cit49","doi-asserted-by":"publisher","DOI":"10.1023\/A:1016212804288"},{"key":"ref50\/cit50","volume-title":"The Biopharmaceutics Classification System Guidance","author":"CDER\/FDA","year":"2006"},{"key":"ref51\/cit51","unstructured":"USP 42, General Chapter\n\u27e8711\u27e9 Dissolution. USP, 2019."},{"key":"ref52\/cit52","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1984.03340400031020"},{"key":"ref53\/cit53","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.77.7.4237-4247.2003"},{"key":"ref54\/cit54","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2014.08.013"},{"key":"ref55\/cit55","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01114-13"},{"key":"ref56\/cit56","first-page":"60","volume":"22","author":"Burnette T. C.","year":"1994","journal-title":"Drug Metab. Dispos."},{"key":"ref57\/cit57","first-page":"55","volume":"22","author":"de Miranda P.","year":"1994","journal-title":"Drug Metab. Dispos."},{"key":"ref58\/cit58","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.40.1.80"},{"key":"ref59\/cit59","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.39.12.2759"},{"key":"ref60\/cit60","doi-asserted-by":"publisher","DOI":"10.3109\/00498259409045899"},{"key":"ref61\/cit61","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-199631010-00001"},{"key":"ref62\/cit62","doi-asserted-by":"publisher","DOI":"10.1177\/106002809603000913"},{"key":"ref63\/cit63","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2011.03.014"},{"key":"ref64\/cit64","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/22.2.355"},{"key":"ref65\/cit65","doi-asserted-by":"publisher","DOI":"10.1038\/nrd1853"},{"key":"ref66\/cit66","unstructured":"FDA.\nBreakthrough Therapy (2018)\/ https:\/\/www.fda.gov\/patients\/fast-track-breakthrough-therapy-accelerated-approval-priority-review\/breakthrough-therapy (accessed Nov 24, 2021)."},{"key":"ref67\/cit67","doi-asserted-by":"crossref","unstructured":"Workowski, K.; Albrecht, J.; Avery, R.; Chandrasekar, P.; Chemaly, R.; Issa, N.; Kotton, C.; Kumar, P.; Ramesh, M.; Ramgopal, M.; Schiffer, J.; Schreibman, T.; Wald, A.; Ison, M. Pritelivir in immunocompromised patients with mucocutaneous acyclovir resistant herpes simplex virus infections\u2500first case series. Presented at ID Week, Sept 29\u2013Oct 03, 2021; virtual event.","DOI":"10.1093\/ofid\/ofab466.1254"},{"key":"ref68\/cit68","doi-asserted-by":"publisher","DOI":"10.1177\/09564624211006568"},{"key":"ref69\/cit69","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkac165"}],"container-title":["Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acs.jmedchem.2c00668","content-type":"application\/pdf","content-version":"vor","intended-application":"unspecified"},{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acs.jmedchem.2c00668","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,27]],"date-time":"2023-04-27T11:27:24Z","timestamp":1682594844000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/doi\/10.1021\/acs.jmedchem.2c00668"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,6]]},"references-count":69,"journal-issue":{"issue":"20","published-print":{"date-parts":[[2022,10,27]]}},"alternative-id":["10.1021\/acs.jmedchem.2c00668"],"URL":"https:\/\/doi.org\/10.1021\/acs.jmedchem.2c00668","relation":{},"ISSN":["0022-2623","1520-4804"],"issn-type":[{"value":"0022-2623","type":"print"},{"value":"1520-4804","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,6]]}}}